Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
Arch Bronconeumol
; 48(7): 247-57, 2012 Jul.
Article
em En, Es
| MEDLINE
| ID: mdl-22561012
ABSTRACT
Recognizing the clinical heterogeneity of COPD suggests a specific therapeutic approach directed by the so-called clinical phenotypes of the disease. The Spanish COPD Guidelines (GesEPOC) is an initiative of SEPAR, which, together with the scientific societies involved in COPD patient care, and the Spanish Patient Forum, has developed these new clinical practice guidelines. This present article describes the severity classification and the pharmacological treatment of stable COPD. GesEPOC identifies four clinical phenotypes with differential treatment non-exacerbator, mixed COPD-asthma, exacerbator with emphysema and exacerbator with chronic bronchitis. Pharmacological treatment of COPD is based on bronchodilation in addition to other drugs depending on the clinical phenotype and severity. Severity is established by the BODE/BODEx multidimensional scales. Severity can also be approximated by assessing airflow obstruction, dyspnea, level of physical activity and history of exacerbations. GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Medicamentos para o Sistema Respiratório
/
Doença Pulmonar Obstrutiva Crônica
Tipo de estudo:
Guideline
/
Prognostic_studies
País como assunto:
Europa
Idioma:
En
/
Es
Ano de publicação:
2012
Tipo de documento:
Article